Number of the records: 1  

The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity

  1. 1.
    SYSNO ASEP0363114
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleThe Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity
    Author(s) Maletínská, Lenka (UOCHB-X) RID, ORCID
    Matyšková, Resha (UOCHB-X)
    Maixnerová, Jana (UOCHB-X)
    Sýkora, D. (CZ)
    Pýchová, Miroslava (UOCHB-X)
    Špolcová, Andrea (UOCHB-X) RID, ORCID
    Blechová, Miroslava (UOCHB-X)
    Drápalová, J. (CZ)
    Lacinová, Z. (CZ)
    Haluzík, M. (CZ)
    Železná, Blanka (UOCHB-X) RID, ORCID
    Number of authors11
    Source TitleMolecular and Cellular Endocrinology. - : Elsevier - ISSN 0303-7207
    Roč. 343, 1/2 (2011), s. 55-62
    Number of pages8 s.
    Languageeng - English
    CountryIE - Ireland
    KeywordsGHS-R ; [D-Lys3]GHRP-6 ; ovariectomized obese mice
    Subject RIVCE - Biochemistry
    R&D ProjectsGA303/09/0744 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000295349200007
    DOI10.1016/j.mce.2011.06.006
    AnnotationGhrelin receptor antagonist [D-Lys3]GHRP-6 after seven days of subcutaneous treatment markedly decreased food intake in OVX mice fed both HF and standard diets; furthermore, it reduced body weight and blood glucose, insulin and leptin, and increased beta-hydroxybutyrate level and uncoupling-protein-1 mRNA in brown adipose tissue. Pair-feeding revealed that effect of [D-Lys3]GHRP-6 was primary anorexigenic. Estrogen supplementation reduced anorexigenic effects of [D-Lys3]GHRP-6. OVX [D-Lys3]GHRP-6 treatment in mice on HF diet resulted in markedly increased circulating level and liver expression of a major metabolic regulator, fibroblast growth factor 21. Our data suggest that ghrelin antagonists could be especially beneficial in individuals with common obesity combined with estrogen deficiency.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.